REGENERX BIOPHARMACEUTICALS INC Annual Weighted Average Number of Shares Outstanding, Diluted from 2015 to 2022

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2015 to 2022.
  • Regenerx Biopharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2023 was 144M shares, unchanged year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 144M shares, a 3.58% increase from 2021.
  • Regenerx Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 139M shares, a 3.93% increase from 2020.
  • Regenerx Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 133M shares, a 1.82% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 144M +4.96M +3.58% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-11
2021 139M +5.24M +3.93% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-11
2020 133M +2.39M +1.82% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 131M +10.3M +8.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 121M -213K -0.18% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 121M -4.99M -3.97% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 126M +24.4M +24% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 102M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.